# Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy

> **NCT00691093** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 823 (actual)

## Conditions studied

- Overactive Bladder
- Urinary Incontinence

## Interventions

- **DRUG:** fesoterodine

## Key facts

- **NCT ID:** NCT00691093
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 823 (ACTUAL)
- **Last updated:** 2018-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00691093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00691093, "Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00691093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*